VBI Vaccines (VBIV)
NASDAQ:VBIV
Holding VBIV?
Track your performance easily

VBI Vaccines (VBIV) Technical Analysis

2,222 Followers

Technical Sentiment

Overall Consensus
Buy
13Bullish
4Neutral
5Bearish
Technical Analysis Consensus
Neutral
3Bullish
4Neutral
3Bearish
Moving Average Consensus
Strong Buy
10Bullish
0Neutral
2Bearish
VBI Vaccines’s (VBIV) Moving Averages Convergence Divergence (MACD) indicator is 0.04, suggesting VBI Vaccines is a Sell.
VBI Vaccines’s (VBIV) 20-Day exponential moving average is 0.70, while VBI Vaccines’s (VBIV) share price is $0.763, making it a Buy.
VBI Vaccines’s (VBIV) 50-Day exponential moving average is 0.66, while VBI Vaccines’s (VBIV) share price is $0.763, making it a Buy.

VBI Vaccines (VBIV) Pivot Points

Sep 19, 2024, 04:47 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.68
0.71
0.75
0.78
0.82
0.85
0.89
Fibonacci
0.71
0.74
0.75
0.78
0.81
0.82
0.85
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

VBI Vaccines (VBIV) Moving Averages

Sep 19, 2024, 04:47 PM
Period
Simple
Exponential
MA5
0.77Sell
0.76Sell
MA10
0.75Buy
0.74Buy
MA20
0.68Buy
0.70Buy
MA50
0.64Buy
0.66Buy
MA100
0.62Buy
0.65Buy
MA200
0.62Buy
0.71Buy
VBI Vaccines’s (VBIV) 10-Day exponential moving average is 0.74, while VBI Vaccines’s (VBIV) share price is $0.763, making it a Buy.
VBI Vaccines’s (VBIV) 100-Day exponential moving average is 0.65, while VBI Vaccines’s (VBIV) share price is $0.763, making it a Buy.
VBI Vaccines’s (VBIV) stock price is $0.763 and VBI Vaccines’s (VBIV) 50-day simple moving average is 0.64, creating a Buy signal.
VBI Vaccines’s (VBIV) stock price is $0.763 and VBI Vaccines’s (VBIV) 100-day simple moving average is 0.62, creating a Buy signal.
VBI Vaccines’s (VBIV) stock price is $0.763 and VBI Vaccines’s (VBIV) 200-day simple moving average is 0.62, creating a Buy signal.

VBI Vaccines (VBIV) Technical Indicators

Sep 19, 2024, 04:47 PM
Name
Value
Implied Action
RSI (14)
66.57
Neutral
STOCH (9,6)
82.88
Sell
STOCHRSI (14)
88.92
Sell
MACD (12,26)
0.04
Sell
ADX (14)
27.70
Neutral
Williams %R
-24.62
Buy
CCI (14)
91.25
Neutral
ATR (14)
0.05
-
Ultimate Oscillator
60.78
Neutral
ROC
22.58
Buy
VBI Vaccines’s (VBIV) Relative Strength Index (RSI) is 66.57, creating a Neutral signal.
VBI Vaccines’s (VBIV) Trend Strength Indicator (ADX) is 27.70, creating a Neutral signal.
VBI Vaccines’s (VBIV) Commodity Channel Index (CCI) is 91.25, creating a Neutral signal.
VBI Vaccines’s (VBIV) Price Rate of Change (ROC) is 22.58, creating a Buy signal.

FAQ

Is VBIV a Buy, Hold, or Sell?
Based on VBIV’s technical indicators, VBIV is a Buy.
    What is VBIV’s RSI (14)?
    VBIV’s RSI (14) is 66.57, which suggests VBIV is a Neutral.
      What is VBIV’s MACD?
      VBIV’s MACD is 0.04, which suggests VBIV is a Sell.
        What is VBIV’s 5-day moving average?
        VBIV’s 5-day moving average is 0.77, which suggests VBIV is a Sell.
          What is VBIV’s 20-day moving average?
          VBIV 20-day moving average is 0.68, which suggests VBIV is a Buy.
            What is VBIV’s 50-day moving average?
            VBIV’s 50-day moving average is 0.64, which suggests VBIV is a Buy.
              What is VBIV’s 200-day moving average?
              VBIV’s 200-day moving average is 0.62, which suggests VBIV is a Buy.
                What is VBIV’s Williams % R (14)?
                VBIV’s Williams % R (14) is -24.62, which suggests VBIV is a Buy.
                  What is VBIV’s CCI (14)?
                  VBIV’s CCI (14) is 91.25, which suggests VBIV is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis